Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NEXM
DateTimeSourceHeadlineSymbolCompany
09/10/20104:11PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
09/10/20103:31PMBusiness WireNexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus BiosciencesNASDAQ:NEXMNexmed (MM)
08/31/20104:18PMEdgar (US Regulatory)Securities Registration Statement (S-1)NASDAQ:NEXMNexmed (MM)
08/25/201010:00AMBusiness WireNexMed To Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:NEXMNexmed (MM)
08/23/20108:00AMBusiness WireNexMed Receives Additional Patent Coverage for IsraelNASDAQ:NEXMNexmed (MM)
08/19/20104:20PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
08/17/20105:03AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NEXMNexmed (MM)
08/12/20104:10PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
08/11/20108:15AMBusiness WireNexMed Announces 2010 Second Quarter Financial Results Conference CallNASDAQ:NEXMNexmed (MM)
08/06/20101:34PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NEXMNexmed (MM)
07/26/201011:36AMBusiness WireMohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USANASDAQ:NEXMNexmed (MM)
06/21/20108:15AMGlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.NASDAQ:NEXMNexmed (MM)
06/17/20104:05PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
06/15/20101:48PMBusiness WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
06/15/20108:20AMBusiness WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
06/10/201012:30PMBusiness WireNexMed Provides Update on Canadian Filing for Vitaros®NASDAQ:NEXMNexmed (MM)
05/27/201012:16PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
05/26/20105:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
05/26/20102:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
05/25/20104:00PMBusiness WireNexMed Announces Expansion of Senior Business Development TeamNASDAQ:NEXMNexmed (MM)
05/17/20104:11PMBusiness WireNexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDANASDAQ:NEXMNexmed (MM)
05/13/20104:09PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
05/12/20104:01PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
05/12/20103:30PMBusiness WireNexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound HealingNASDAQ:NEXMNexmed (MM)
05/10/20104:19PMBusiness WireNexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...NASDAQ:NEXMNexmed (MM)
05/07/20104:50AMGlobeNewswire Inc.BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfitNASDAQ:NEXMNexmed (MM)
05/06/20103:45PMBusiness WireNexMed Expands Scientific Advisory Board with Appointment of Key Industry LeadersNASDAQ:NEXMNexmed (MM)
05/05/20103:36PMBusiness WireNexMed Announces Patent Allowance for NexACT® in CanadaNASDAQ:NEXMNexmed (MM)
04/30/20101:53PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:NEXMNexmed (MM)
04/29/20105:06AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
 Showing the most relevant articles for your search:NASDAQ:NEXM